Primary MM sample clinical characteristics
Sample ID . | Sex . | Age, y . | M protein type at diagnosis . | ISS . | Purity (%) . |
---|---|---|---|---|---|
MM.01 | Male | 80 | IgA κ | II | 73 |
MM.02 | Male | 86 | IgG κ | NA | 91 |
MM.03 | Male | 72 | IgG κ | II | 98 |
MM.04 | Female | 74 | IgG κ | I | 90 |
MM.05 | Female | 51 | IgG κ | I | 89 |
MM.07 | Female | 77 | IgG λ | I | 96 |
MM.08 | Male | 59 | Bence-Jones κ | I | 96 |
MM.10 | Female | 75 | IgG κ | NA | 100 |
Sample ID . | Sex . | Age, y . | M protein type at diagnosis . | ISS . | Purity (%) . |
---|---|---|---|---|---|
MM.01 | Male | 80 | IgA κ | II | 73 |
MM.02 | Male | 86 | IgG κ | NA | 91 |
MM.03 | Male | 72 | IgG κ | II | 98 |
MM.04 | Female | 74 | IgG κ | I | 90 |
MM.05 | Female | 51 | IgG κ | I | 89 |
MM.07 | Female | 77 | IgG λ | I | 96 |
MM.08 | Male | 59 | Bence-Jones κ | I | 96 |
MM.10 | Female | 75 | IgG κ | NA | 100 |
IgG, immunoglobulin G; ISS, International Staging System; NA, not assessed.